从不良事件中断的风险:单独免疫疗法与化学疗法相结合:系统性审查和网络元分析
Sangwon Shin1, Jimin Moon1, Chiyoon Oum1
1Lunit, 4th to 8th floors, 374, Gangnam-daero, Gangnam-gu, Seoul, Republic of Korea.
化学疗法与免疫疗法 (化疗-IO) 结合,与单一疗法 (单一-IO) 相比,由于不良事件导致的治疗中止率增加. 一部分患者可能会从单一IO中获益更多,需要进一步的研究来识别这些患者.
科学领域:
- 在瘤学瘤学.
- 临床试验 临床试验
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫疗法与化疗 (化疗-IO) 结合提供了优异的结果,但增加了与治疗相关的不良事件 (TRAE),导致停止治疗.
- 这项研究比较了在一线癌症治疗中单一IO和化学IO之间的停药率.
结论:
- 化疗-IO与由于TRAE,任何AE和TEAE而导致更高的治疗中止率有关.
- 治疗持续时间会影响结果,这表明单一IO可能对特定的患者更有益.
- 进一步的研究至关重要,以确定哪些患者将从单一IO治疗中获得更多益处,而不是组合治疗.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
